Back to results
US 2003/0216301 A1Published application
Thrombin inhibitors
AssigneeMerk & Co., Inc.
InventorsJames C. Barrow, Philippe G. Nantermet, Harold G. Selnick
Life of this patent
Estimating the term…
Abstract
Compounds of the invention are useful in inhibiting thrombin and associated thrombotic occlusions having the following structure: 1 or a pharmaceutically acceptable salt thereof.
Claims13
A compound of the general formula
- 14
- and pharmaceutically acceptable salts thereof, wherein
- n is 0, 1,2 or 3;
- X is hydrogen, halogen or C1-4 alkyl;
- Y is a bond or —CH(R)—;
- W is a bond or —(C(R4)(R5))1-5;
- R and R1 are independently selected from the group consisting of hydrogen, C1-4 alkyl, cycloC3-7alkyl, aryl or a 5- to 7-membered heterocycle;
- and
- R2, R3, R4, and R5, in each occurrence, are independently selected from the group consisting of hydrogen and C1-4 alkyl.
6 more elements
Dependencies are inferred from the claim text.